China Resources Pharmaceutical Group Limited Stock
Stocks
3320
HK0000311099
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
16:08:16 07/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 4.425 HKD | -0.23% |
|
-1.01% | -0.56% |
| 09-01 | China Resources Pharma Unit's Bond Program Registration Accepted in China | MT |
| 08-24 | China Resources Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 27.86B 3.55B 3.06B 2.88B 2.63B 4.92B 335B 4.93B 34B 13.19B 172B 13.34B 13.05B 555B | P/E 2026 * |
5.7x | P/E 2027 * | 5.35x |
|---|---|---|---|---|---|
| Enterprise Value | 77.1B 9.83B 8.46B 7.96B 7.27B 13.6B 928B 13.64B 94.07B 36.5B 476B 36.92B 36.12B 1,534B | EV / Sales 2026 * |
0.23x | EV / Sales 2027 * | 0.21x |
| Free-Float |
29.17% | Yield 2026 * |
4.53% | Yield 2027 * | 4.89% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 3320 | Delayed | |
Boerse Muenchen
| 640 | Real-time | |
|
Tradegate
| 640 | Real-time | |
|
Deutsche Boerse AG
| 640 | Delayed | |
|
Börse Stuttgart
| 640 | Delayed |
| 1 day | -0.23% | ||
| 1 week | -1.01% | ||
| Current month | -1.01% | ||
| 1 month | -8.57% | ||
| 3 months | -6.84% | ||
| 6 months | -2.75% | ||
| Current year | -0.56% |
| 1 week | 4.38 |  | 4.5 |
| 1 month | 4.38 | | 5.02 |
| Current year | 4.22 | | 6.53 |
| 1 year | 4.22 | | 6.53 |
| 3 years | 4.22 | | 7.11 |
| 5 years | 3.18 | | 8.13 |
| 10 years | 3.18 | | 13.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Cheng
PSD | President | 47 | 26/08/2025 |
Rong Hui Deng
DFI | Director of Finance/CFO | 54 | 13/06/2023 |
Wing Yi Wan
SEC | Corporate Secretary | - | 15/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ting Mei Fu
BRD | Director/Board Member | 59 | 01/06/2016 |
Ke Jian Zhang
BRD | Director/Board Member | 70 | 20/06/2016 |
Xiao Song Bai
CHM | Chairman | 55 | 29/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/4/20 | Other | Chief Executive Officer | 200,000 | 0.0032% | ||
| 31/3/20 | Other | Chief Executive Officer | 100,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.23% | -1.01% | -10.43% | -10.43% | 3.55B | |
| -0.88% | -2.15% | +58.05% | +105.26% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +74.19% | 663B | |
| -1.44% | +0.38% | +20.65% | +76.13% | 453B | |
| -0.56% | +0.60% | +31.40% | +38.28% | 352B | |
| -2.56% | +2.50% | +23.48% | +42.55% | 304B | |
| +1.50% | +1.92% | +1.85% | +12.64% | 252B | |
| -1.55% | +1.11% | +54.15% | +75.59% | 236B | |
| -0.09% | +2.19% | -13.88% | -55.82% | 206B | |
| -0.15% | +3.65% | +31.24% | +103.39% | 187B | |
| Average | -0.72% | +0.84% | +25.08% | +46.18% | 368.19B | |
| Weighted average by Cap. | -0.91% | +0.62% | +37.82% | +67.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 328B 41.84B 36.01B 33.88B 30.95B 57.89B 3,951B 58.05B 400B 155B 2,027B 157B 154B 6,530B | 341B 43.46B 37.4B 35.18B 32.14B 60.13B 4,103B 60.29B 416B 161B 2,105B 163B 160B 6,782B |
| Net income | 4.8B 612M 526M 495M 452M 846M 57.76B 849M 5.85B 2.27B 29.63B 2.3B 2.25B 95.47B | 5.16B 658M 566M 532M 486M 910M 62.09B 912M 6.29B 2.44B 31.86B 2.47B 2.42B 103B |
| Net Debt | 49.24B 6.28B 5.4B 5.08B 4.64B 8.69B 593B 8.71B 60.07B 23.31B 304B 23.58B 23.06B 980B | 42.53B 5.42B 4.67B 4.39B 4.01B 7.5B 512B 7.52B 51.89B 20.13B 263B 20.37B 19.92B 846B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/09/26 | HK$4.425 | -0.23% | 10,364,000 |
| 04/09/26 | HK$4.435 | +0.57% | 10,075,658 |
| 03/09/26 | HK$4.410 | 0.00% | 8,985,000 |
| 02/09/26 | HK$4.410 | -0.79% | 12,010,600 |
| 01/09/26 | HK$4.445 | -0.56% | 10,613,082 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3320 Stock
Select your edition
All financial news and data tailored to specific country editions
